VoronoiBetaKRX Filings & Disclosures 2026
Latest Voronoi (310210) DART disclosures in 2026 — including the most recent annual report filed on March 20, 2026. SignalX aggregates every new annual, half-year, quarterly, and material-event filing for Voronoi (310210) (KRX code 310210) from DART (Korea Financial Supervisory Service), with AI-powered English summaries of business overview, risk factors, and management discussion.
Latest 2026 DART Filing Dates
AI Annual Report AnalysisLatest Annual (2025-12-31)
Risk Factors
- • USD 10% FX move → ±KRW 1.5B after-tax impact on equity (up from ±KRW 1.1B in 2024)
- • Total debt surged to KRW 67.4B from KRW 7.2B YoY; debt ratio jumped to 64.97% from 10.91%
Management Discussion & Analysis
- • Net loss KRW 42.7B (vs. KRW 32.6B prior year, +30.9% YoY); operating loss KRW 54.4B (vs. KRW 36.3B, +49.7%); revenue KRW 7.5B (prior year: nil)
- • VRN04 tech-asset sale to Anvia Therapeutics generated KRW 7.5B revenue; R&D expense rose KRW 13.1B and stock-based compensation KRW 7.2B, widening operating loss
Business Overview
- • Voronoi (보로노이) business model: preclinical-to-Phase 1/2 Kinase inhibitor developer, monetizing via global license-out and tech-asset sales
- • Sep 2025: VRN04 (RIPK1) program tech-asset sold to Anvia Therapeutics, Inc. — first non-license-out deal structure disclosed in this filing
Annual Reports ArchiveAnnual
AI-powered English analysis of Voronoi annual reports filed with DART.
Financial SummaryDART
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|
| Balance Sheet | |||||
| Total Assets | KRW 40.2B | KRW 64.0B | KRW 94.7B | KRW 73.7B | KRW 171.2B |
| Equity | KRW 6.9B | KRW 34.3B | KRW 81.3B | KRW 66.4B | KRW 103.8B |
| Debt Ratio | 480.5% | 86.7% | 16.4% | 10.9% | 65.0% |
| Cash Flow | |||||
| Operating CF | -KRW 17.6B | -KRW 16.3B | -KRW 28.8B | -KRW 29.1B | -KRW 72.1B |
| CapEx | KRW 575.8M | KRW 545.8M | KRW 1.1B | KRW 1.1B | KRW 1.6B |
Source: KIFRS consolidated financial statements from Voronoi (KRX:310210) annual reports on DART. All figures in KRW.
Latest 2026 DART Filings
| Form | Filing Date | Period | Analysis | DART |
|---|---|---|---|---|
Annual Report | Mar 20, 2026 | Dec 31, 2025 | Analysis |
Frequently Asked Questions
What are the latest Voronoi DART filings in 2026?
Voronoi (KRX code 310210) has filed an annual report on March 20, 2026 with DART. SignalX tracks every new DART disclosure with AI-powered English summaries of business overview, risk factors, and management discussion.
When did Voronoi file its most recent annual report?
Voronoi filed its most recent annual report on March 20, 2026. The annual report includes audited financial statements, business overview, risk factors, and management discussion (MD&A), all available on SignalX with AI-generated English summaries and KIFRS financial data.
What is Voronoi's KRX stock code?
Voronoi's KRX stock code is 310210. The 6-digit stock code is the KRX standard identifier for every listed security. You can use stock code 310210 to look up all Voronoi disclosures on DART, or browse them here on SignalX with AI-powered English analysis.
How often does Voronoi file with DART?
Korean listed companies file an annual report once per year (typically within 90 days of fiscal year-end), a half-year report once mid-year, and quarterly reports for Q1 and Q3 — three regular periodic disclosures plus the annual. Material event reports are filed as needed when corporate events occur. SignalX monitors DART daily.
What is the difference between annual, half-year, and quarterly reports in Korea?
An annual report is a comprehensive filing with audited financials, business overview, and risk factors — analogous to the US 10-K. A half-year (interim) report covers H1 results. Quarterly reports cover Q1 or Q3 — analogous to the US 10-Q but Korea publishes only two quarterly reports per year (with the half-year report covering Q2). SignalX provides AI-generated English summaries for all three filing types for Voronoi.
Where can I find Voronoi financial data and KIFRS metrics?
SignalX extracts KIFRS consolidated financial data from Voronoi annual reports, including revenue, gross profit, operating income, net income, total assets, stockholders' equity, EPS (basic/diluted), operating cash flow, and capital expenditure — all in KRW. Multi-year financial trends are displayed in the Financial Summary table above.
Source: DART (Korea Financial Supervisory Service) · AI summaries generated from the original Korean filing (English output) · Beta: coverage is expanding